• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Advaxis cuts staff as it seeks partner for troubled cancer vaccine fiercebiotech
    June 11, 2018
    Just six weeks after taking the helm of biotech Advaxis, CEO Ken Berlin has launched a search for a partner for its stalled lead axalimogene filolisbac (AXAL) and will scale back trials of the immunotherapy in order to bring earlier stage programs forward
  • New leadership at Advaxis biospectrumasia
    April 25, 2018
    Kenneth A. Berlin appointed President, CEO and Director; Dr. Andres A. Gutierrez named Chief Medical Officer; Sara Bonstein, CFO, to depart
  • FDA Halts Advaxis Study Following Patient Death biospace
    March 14, 2018
    Shares of Advaxis, Inc. announced that the U.S. Food and Drug Administration halted a Phase I/II trial that uses an AstraZeneca Pharmaceuticals LPdrug following the death of a patient.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service